1. Home
  2. EIG vs PHAR Comparison

EIG vs PHAR Comparison

Compare EIG & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$42.45

Market Cap

980.0M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$16.98

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EIG
PHAR
Founded
2000
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.0M
1.1B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
EIG
PHAR
Price
$42.45
$16.98
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
172.8K
9.0K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.08%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$858,700,000.00
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
$1.26
$2.51
P/E Ratio
$90.00
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$8.39
52 Week High
$49.98
$21.34

Technical Indicators

Market Signals
Indicator
EIG
PHAR
Relative Strength Index (RSI) 56.83 49.59
Support Level $41.47 $16.35
Resistance Level $43.01 $17.49
Average True Range (ATR) 0.74 0.53
MACD 0.02 -0.03
Stochastic Oscillator 53.92 24.53

Price Performance

Historical Comparison
EIG
PHAR

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: